AnalysisMajor Drugmakers Reshape Cancer Treatment Through Billion-Dollar Acquisitions, FDA ApprovalsViaNews Editorial Team (Markets)•Feb 15, 2026
TechnologyAbbVie Strikes Deal to Cut Drug Prices, Boost U.S. R&D InvestmentViaNews Editorial Team (Markets)•Jan 13, 2026